LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Lamprecht, Dirk A"
  2. AU="Tseng, Chiu-Chen"

Search results

Result 1 - 10 of total 15

Search options

  1. Article: Mycobacterium tuberculosis H2S Functions as a Sink to Modulate Central Metabolism, Bioenergetics, and Drug Susceptibility

    Kunota, Tafara T. R. / Rahman, Md. Aejazur / Truebody, Barry E. / Mackenzie, Jared S. / Saini, Vikram / Lamprecht, Dirk A. / Adamson, John H. / Sevalkar, Ritesh R. / Lancaster, Jack R. / Berney, Michael / Glasgow, Joel N. / Steyn, Adrie J. C.

    Antioxidants. 2021 Aug. 13, v. 10, no. 8

    2021  

    Abstract: H₂S is a potent gasotransmitter in eukaryotes and bacteria. Host-derived H₂S has been shown to profoundly alter M. tuberculosis (Mtb) energy metabolism and growth. However, compelling evidence for endogenous production of H₂S and its role in Mtb ... ...

    Abstract H₂S is a potent gasotransmitter in eukaryotes and bacteria. Host-derived H₂S has been shown to profoundly alter M. tuberculosis (Mtb) energy metabolism and growth. However, compelling evidence for endogenous production of H₂S and its role in Mtb physiology is lacking. We show that multidrug-resistant and drug-susceptible clinical Mtb strains produce H₂S, whereas H₂S production in non-pathogenic M. smegmatis is barely detectable. We identified Rv3684 (Cds1) as an H₂S-producing enzyme in Mtb and show that cds1 disruption reduces, but does not eliminate, H₂S production, suggesting the involvement of multiple genes in H₂S production. We identified endogenous H₂S to be an effector molecule that maintains bioenergetic homeostasis by stimulating respiration primarily via cytochrome bd. Importantly, H₂S plays a key role in central metabolism by modulating the balance between oxidative phosphorylation and glycolysis, and it functions as a sink to recycle sulfur atoms back to cysteine to maintain sulfur homeostasis. Lastly, Mtb-generated H₂S regulates redox homeostasis and susceptibility to anti-TB drugs clofazimine and rifampicin. These findings reveal previously unknown facets of Mtb physiology and have implications for routine laboratory culturing, understanding drug susceptibility, and improved diagnostics.
    Keywords Mycobacterium tuberculosis ; cysteine ; diagnostic techniques ; enzymes ; eukaryotic cells ; glycolysis ; homeostasis ; multiple drug resistance ; oxidative phosphorylation ; rifampicin ; sulfur
    Language English
    Dates of publication 2021-0813
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2704216-9
    ISSN 2076-3921
    ISSN 2076-3921
    DOI 10.3390/antiox10081285
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  2. Article: Mycobacterium tuberculosis

    Kunota, Tafara T R / Rahman, Md Aejazur / Truebody, Barry E / Mackenzie, Jared S / Saini, Vikram / Lamprecht, Dirk A / Adamson, John H / Sevalkar, Ritesh R / Lancaster, Jack R / Berney, Michael / Glasgow, Joel N / Steyn, Adrie J C

    Antioxidants (Basel, Switzerland)

    2021  Volume 10, Issue 8

    Abstract: ... ...

    Abstract H
    Language English
    Publishing date 2021-08-13
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2704216-9
    ISSN 2076-3921
    ISSN 2076-3921
    DOI 10.3390/antiox10081285
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis.

    Mackenzie, Jared S / Lamprecht, Dirk A / Asmal, Rukaya / Adamson, John H / Borah, Khushboo / Beste, Dany J V / Lee, Bei Shi / Pethe, Kevin / Rousseau, Simon / Krieger, Inna / Sacchettini, James C / Glasgow, Joel N / Steyn, Adrie J C

    Nature communications

    2020  Volume 11, Issue 1, Page(s) 6092

    Abstract: The approval of bedaquiline (BDQ) for the treatment of tuberculosis has generated substantial interest in inhibiting energy metabolism as a therapeutic paradigm. However, it is not known precisely how BDQ triggers cell death in Mycobacterium tuberculosis ...

    Abstract The approval of bedaquiline (BDQ) for the treatment of tuberculosis has generated substantial interest in inhibiting energy metabolism as a therapeutic paradigm. However, it is not known precisely how BDQ triggers cell death in Mycobacterium tuberculosis (Mtb). Using
    MeSH term(s) Anti-Bacterial Agents/pharmacology ; Antitubercular Agents/pharmacology ; Bacterial Proteins/metabolism ; Carbon Cycle/drug effects ; Citric Acid Cycle/drug effects ; Diarylquinolines/pharmacology ; Energy Metabolism/drug effects ; Glycolysis/drug effects ; Glyoxylates ; Mycobacterium tuberculosis/drug effects ; Mycobacterium tuberculosis/genetics ; Mycobacterium tuberculosis/metabolism ; Oxidative Phosphorylation ; Tuberculosis/microbiology
    Chemical Substances Anti-Bacterial Agents ; Antitubercular Agents ; Bacterial Proteins ; Diarylquinolines ; Glyoxylates ; bedaquiline (78846I289Y) ; glyoxylic acid (JQ39C92HH6)
    Language English
    Publishing date 2020-11-30
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-020-19959-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis.

    Lupien, Andréanne / Foo, Caroline Shi-Yan / Savina, Svetlana / Vocat, Anthony / Piton, Jérémie / Monakhova, Natalia / Benjak, Andrej / Lamprecht, Dirk A / Steyn, Adrie J C / Pethe, Kevin / Makarov, Vadim A / Cole, Stewart T

    PLoS pathogens

    2020  Volume 16, Issue 1, Page(s) e1008270

    Abstract: The emergence of multi-drug (MDR-TB) and extensively-drug resistant tuberculosis (XDR-TB) is a major threat to the global management of tuberculosis (TB) worldwide. New chemical entities are of need to treat drug-resistant TB. In this study, the mode of ... ...

    Abstract The emergence of multi-drug (MDR-TB) and extensively-drug resistant tuberculosis (XDR-TB) is a major threat to the global management of tuberculosis (TB) worldwide. New chemical entities are of need to treat drug-resistant TB. In this study, the mode of action of new, potent quinazoline derivatives was investigated against Mycobacterium tuberculosis (M. tb). Four derivatives 11626141, 11626142, 11626252 and 11726148 showed good activity (MIC ranging from 0.02-0.09 μg/mL) and low toxicity (TD50 ≥ 5μg/mL) in vitro against M. tb strain H37Rv and HepG2 cells, respectively. 11626252 was the most selective compound from this series. Quinazoline derivatives were found to target cytochrome bc1 by whole-genome sequencing of mutants selected with 11626142. Two resistant mutants harboured the transversion T943G (Trp312Gly) and the transition G523A (Gly175Ser) in the cytochrome bc1 complex cytochrome b subunit (QcrB). Interestingly, a third mutant QuinR-M1 contained a mutation in the Rieske iron-sulphur protein (QcrA) leading to resistance to quinazoline and other QcrB inhibitors, the first report of cross-resistance involving QcrA. Modelling of both QcrA and QcrB revealed that all three resistance mutations are located in the stigmatellin pocket, as previously observed for other QcrB inhibitors such as Q203, AX-35, and lansoprazole sulfide (LPZs). Further analysis of the mode of action in vitro revealed that 11626252 exposure leads to ATP depletion, a decrease in the oxygen consumption rate and also overexpression of the cytochrome bd oxidase in M. tb. Our findings suggest that quinazoline-derived compounds are a new and attractive chemical entity for M. tb drug development targeting two separate subunits of the cytochrome bc1 complex.
    MeSH term(s) Antitubercular Agents/chemistry ; Antitubercular Agents/pharmacology ; Bacterial Proteins/antagonists & inhibitors ; Bacterial Proteins/genetics ; Bacterial Proteins/metabolism ; Drug Resistance, Bacterial ; Electron Transport Complex III/antagonists & inhibitors ; Electron Transport Complex III/genetics ; Electron Transport Complex III/metabolism ; Humans ; Microbial Sensitivity Tests ; Mutation ; Mycobacterium tuberculosis/drug effects ; Mycobacterium tuberculosis/genetics ; Mycobacterium tuberculosis/metabolism ; Quinazolines/chemistry ; Quinazolines/pharmacology ; Tuberculosis, Multidrug-Resistant/drug therapy ; Tuberculosis, Multidrug-Resistant/microbiology
    Chemical Substances 2-ethylthio-4-methylaminoquinazoline ; Antitubercular Agents ; Bacterial Proteins ; Quinazolines ; Electron Transport Complex III (EC 7.1.1.8)
    Language English
    Publishing date 2020-01-23
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2205412-1
    ISSN 1553-7374 ; 1553-7374
    ISSN (online) 1553-7374
    ISSN 1553-7374
    DOI 10.1371/journal.ppat.1008270
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Mycobacterium tuberculosis arrests host cycle at the G1/S transition to establish long term infection.

    Cumming, Bridgette M / Rahman, Md Aejazur / Lamprecht, Dirk A / Rohde, Kyle H / Saini, Vikram / Adamson, John H / Russell, David G / Steyn, Adrie J C

    PLoS pathogens

    2017  Volume 13, Issue 5, Page(s) e1006389

    Abstract: Signals modulating the production of Mycobacterium tuberculosis (Mtb) virulence factors essential for establishing long-term persistent infection are unknown. The WhiB3 redox regulator is known to regulate the production of Mtb virulence factors, however ...

    Abstract Signals modulating the production of Mycobacterium tuberculosis (Mtb) virulence factors essential for establishing long-term persistent infection are unknown. The WhiB3 redox regulator is known to regulate the production of Mtb virulence factors, however the mechanisms of this modulation are unknown. To advance our understanding of the mechanisms involved in WhiB3 regulation, we performed Mtb in vitro, intraphagosomal and infected host expression analyses. Our Mtb expression analyses in conjunction with extracellular flux analyses demonstrated that WhiB3 maintains bioenergetic homeostasis in response to available carbon sources found in vivo to establish Mtb infection. Our infected host expression analysis indicated that WhiB3 is involved in regulation of the host cell cycle. Detailed cell-cycle analysis revealed that Mtb infection inhibited the macrophage G1/S transition, and polyketides under WhiB3 control arrested the macrophages in the G0-G1 phase. Notably, infection with the Mtb whiB3 mutant or polyketide mutants had little effect on the macrophage cell cycle and emulated the uninfected cells. This suggests that polyketides regulated by Mtb WhiB3 are responsible for the cell cycle arrest observed in macrophages infected with the wild type Mtb. Thus, our findings demonstrate that Mtb WhiB3 maintains bioenergetic homeostasis to produce polyketide and lipid cyclomodulins that target the host cell cycle. This is a new mechanism whereby Mtb modulates the immune system by altering the host cell cycle to promote long-term persistence. This new knowledge could serve as the foundation for new host-directed therapeutic discovery efforts that target the host cell cycle.
    Language English
    Publishing date 2017-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2205412-1
    ISSN 1553-7374 ; 1553-7366
    ISSN (online) 1553-7374
    ISSN 1553-7366
    DOI 10.1371/journal.ppat.1006389
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Correction: Mycobacterium tuberculosis arrests host cycle at the G1/S transition to establish long term infection.

    Cumming, Bridgette M / Rahman, Md Aejazur / Lamprecht, Dirk A / Rohde, Kyle H / Saini, Vikram / Adamson, John H / Russell, David G / Steyn, Adrie J C

    PLoS pathogens

    2017  Volume 13, Issue 7, Page(s) e1006490

    Abstract: This corrects the article DOI: 10.1371/journal.ppat.1006389.]. ...

    Abstract [This corrects the article DOI: 10.1371/journal.ppat.1006389.].
    Language English
    Publishing date 2017-07-14
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 2205412-1
    ISSN 1553-7374 ; 1553-7366
    ISSN (online) 1553-7374
    ISSN 1553-7366
    DOI 10.1371/journal.ppat.1006490
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Compromised Metabolic Reprogramming Is an Early Indicator of CD8

    Russell, Shannon L / Lamprecht, Dirk A / Mandizvo, Tawanda / Jones, Terrence T / Naidoo, Vanessa / Addicott, Kelvin W / Moodley, Chivonne / Ngcobo, Bongani / Crossman, David K / Wells, Gordon / Steyn, Adrie J C

    Cell reports

    2019  Volume 29, Issue 11, Page(s) 3564–3579.e5

    Abstract: The immunometabolic mechanisms underlying suboptimal T cell immunity in tuberculosis remain undefined. Here, we examine how chronic Mycobacterium tuberculosis (Mtb) and M. bovis BCG infections rewire metabolic circuits and alter effector functions in ... ...

    Abstract The immunometabolic mechanisms underlying suboptimal T cell immunity in tuberculosis remain undefined. Here, we examine how chronic Mycobacterium tuberculosis (Mtb) and M. bovis BCG infections rewire metabolic circuits and alter effector functions in lung CD8
    MeSH term(s) Animals ; CD8-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; Cells, Cultured ; Cytokines/metabolism ; Female ; Glycolysis ; Hypoglycemic Agents/pharmacology ; Latent Tuberculosis/immunology ; Latent Tuberculosis/microbiology ; Metformin/pharmacology ; Mice ; Mice, Inbred C57BL ; Mitochondria/metabolism ; Mycobacterium bovis/pathogenicity ; Mycobacterium tuberculosis/pathogenicity
    Chemical Substances Cytokines ; Hypoglycemic Agents ; Metformin (9100L32L2N)
    Language English
    Publishing date 2019-12-09
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2019.11.034
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Hydrogen sulfide stimulates Mycobacterium tuberculosis respiration, growth and pathogenesis.

    Saini, Vikram / Chinta, Krishna C / Reddy, Vineel P / Glasgow, Joel N / Stein, Asaf / Lamprecht, Dirk A / Rahman, Md Aejazur / Mackenzie, Jared S / Truebody, Barry E / Adamson, John H / Kunota, Tafara T R / Bailey, Shannon M / Moellering, Douglas R / Lancaster, Jack R / Steyn, Adrie J C

    Nature communications

    2020  Volume 11, Issue 1, Page(s) 557

    Abstract: Hydrogen sulfide ( ... ...

    Abstract Hydrogen sulfide (H
    MeSH term(s) Animals ; Copper/metabolism ; Cystathionine beta-Synthase/genetics ; Cystathionine beta-Synthase/metabolism ; Cytokines/blood ; Disease Models, Animal ; Electron Transport Complex IV/metabolism ; Energy Metabolism ; Female ; Gene Expression Regulation, Bacterial/drug effects ; Homeostasis ; Hydrogen Sulfide/pharmacology ; Lung/pathology ; Macrophages ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Mycobacterium tuberculosis/drug effects ; Mycobacterium tuberculosis/genetics ; Mycobacterium tuberculosis/metabolism ; Mycobacterium tuberculosis/pathogenicity ; RAW 264.7 Cells ; Regulon ; Sulfur/metabolism ; Transcriptome ; Tuberculosis
    Chemical Substances Cytokines ; Sulfur (70FD1KFU70) ; Copper (789U1901C5) ; Electron Transport Complex IV (EC 1.9.3.1) ; Cystathionine beta-Synthase (EC 4.2.1.22) ; Hydrogen Sulfide (YY9FVM7NSN)
    Language English
    Publishing date 2020-01-28
    Publishing country England
    Document type Journal Article
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-019-14132-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.

    Foo, Caroline S / Lupien, Andréanne / Kienle, Maryline / Vocat, Anthony / Benjak, Andrej / Sommer, Raphael / Lamprecht, Dirk A / Steyn, Adrie J C / Pethe, Kevin / Piton, Jérémie / Altmann, Karl-Heinz / Cole, Stewart T

    mBio

    2018  Volume 9, Issue 5

    Abstract: New drugs are needed to control the current tuberculosis (TB) pandemic caused by infection ... ...

    Abstract New drugs are needed to control the current tuberculosis (TB) pandemic caused by infection with
    MeSH term(s) Amides/pharmacology ; Amides/therapeutic use ; Animals ; Antitubercular Agents/pharmacology ; Bacterial Proteins/antagonists & inhibitors ; Cell Line ; Electron Transport Complex III/metabolism ; Female ; Humans ; Macrophages/drug effects ; Macrophages/microbiology ; Mice ; Mice, Inbred BALB C ; Microbial Sensitivity Tests ; Mycobacterium tuberculosis/drug effects ; Piperazines/pharmacology ; Tuberculosis/drug therapy ; Tuberculosis/microbiology
    Chemical Substances Amides ; Antitubercular Agents ; Bacterial Proteins ; Piperazines ; Electron Transport Complex III (EC 7.1.1.8)
    Language English
    Publishing date 2018-10-09
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2557172-2
    ISSN 2150-7511 ; 2161-2129
    ISSN (online) 2150-7511
    ISSN 2161-2129
    DOI 10.1128/mBio.01276-18
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: An enzyme-initiated Smiles rearrangement enables the development of an assay of MshB, the GlcNAc-Ins deacetylase of mycothiol biosynthesis.

    Lamprecht, Dirk A / Muneri, Ndivhuwo O / Eastwood, Hayden / Naidoo, Kevin J / Strauss, Erick / Jardine, Anwar

    Organic & biomolecular chemistry

    2012  Volume 10, Issue 27, Page(s) 5278–5288

    Abstract: MshB is the N-acetyl-1-D-myo-inosityl-2-amino-2-deoxy-D-glucopyranoside (GlcNAc-Ins) deacetylase active as one of the enzymes involved in the biosynthesis of mycothiol (MSH), a protective low molecular weight thiol present only in Mycobacterium ... ...

    Abstract MshB is the N-acetyl-1-D-myo-inosityl-2-amino-2-deoxy-D-glucopyranoside (GlcNAc-Ins) deacetylase active as one of the enzymes involved in the biosynthesis of mycothiol (MSH), a protective low molecular weight thiol present only in Mycobacterium tuberculosis and other actinomycetes. In this study, structural analogues of GlcNAc-Ins in which the inosityl moiety is replaced by a chromophore were synthesized and evaluated as alternate substrates of MshB, with the goal of identifying a compound that would be useful in high-throughput assays of the enzyme. In an unexpected and surprising finding one of the GlcNAc-Ins analogues is shown to undergo a Smiles rearrangement upon MshB-mediated deacetylation, uncovering a free thiol group. We demonstrate that this chemistry can be exploited for the development of the first continuous assay of MshB activity based on the detection of thiol formation by DTNB (Ellman's reagent); such an assay should be ideally suited for the identification of MshB inhibitors by means of high-throughput screens in microplates.
    MeSH term(s) Amidohydrolases/chemistry ; Amidohydrolases/metabolism ; Bacterial Proteins/chemistry ; Bacterial Proteins/metabolism ; Biocatalysis ; Catalytic Domain ; Cysteine/biosynthesis ; Cysteine/chemistry ; Glycopeptides/biosynthesis ; Glycopeptides/chemistry ; Inositol/biosynthesis ; Inositol/chemistry ; Models, Molecular ; Mycobacterium tuberculosis/enzymology ; Substrate Specificity
    Chemical Substances Bacterial Proteins ; Glycopeptides ; mycothiol ; Inositol (4L6452S749) ; Amidohydrolases (EC 3.5.-) ; N-acetyl-1-D-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside deacetylase (EC 3.5.1.-) ; Cysteine (K848JZ4886)
    Language English
    Publishing date 2012-07-21
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2097583-1
    ISSN 1477-0539 ; 1477-0520
    ISSN (online) 1477-0539
    ISSN 1477-0520
    DOI 10.1039/c2ob25429h
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top